American Portfolios Advisors - PARATEK PHARMACEUTICALS INC ownership

PARATEK PHARMACEUTICALS INC's ticker is PRTK and the CUSIP is 699374302. A total of 101 filers reported holding PARATEK PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
American Portfolios Advisors ownership history of PARATEK PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2022$41
+32.3%
160.0%0.00%
Q2 2022$31
-35.4%
160.0%0.00%
Q1 2022$48
-33.3%
160.0%0.00%
Q4 2021$72
-7.7%
160.0%0.00%
Q3 2021$78
-28.4%
160.0%0.00%
Q2 2021$109
-3.5%
160.0%0.00%
Q1 2021$113
+13.0%
160.0%0.00%
Q4 2020$100
+14.9%
160.0%0.00%
Q3 2020$87
+3.6%
160.0%0.00%
Q2 2020$84
+68.0%
160.0%0.00%
Q1 2020$50
-21.9%
160.0%0.00%
Q4 2019$64160.00%
Other shareholders
PARATEK PHARMACEUTICALS INC shareholders Q1 2022
NameSharesValueWeighting ↓
AIGH Capital Management LLC 1,609,398$7,821,0001.64%
Telemetry Investments, L.L.C. 242,514$1,179,0001.59%
Omega Fund Management, LLC 2,606,809$12,669,0001.42%
Bruce & Co., Inc. 1,343,312$6,528,0001.39%
1492 Capital Management LLC 488,309$2,373,0001.20%
Abingworth LLP 1,041,131$5,060,0001.15%
Trellus Management Company, LLC 295,000$1,434,0001.04%
Worth Venture Partners, LLC 389,440$1,893,0000.85%
CM Management, LLC 200,000$972,0000.72%
GENERAL AMERICAN INVESTORS CO INC 1,112,658$5,408,0000.46%
View complete list of PARATEK PHARMACEUTICALS INC shareholders